Mysterious metformin. [Oncologist. 2009] - PubMed

loading

Use of thiazolidinedione and cancer risk in Type 2 diabetes: the Hong Kong diabetes registry. [Diabetes Res Clin Pract. 2012]
Use of thiazolidinedione and cancer risk in Type 2 diabetes: the Hong Kong diabetes registry.
Yang X, So WY, Ma RC, Yu LW, Kong AP, Lee HM, Xu G, Ozaki R, Ko GT, Chan JC. Diabetes Res Clin Pract. 2012 Jul; 97(1):e13-7. Epub 2012 Apr 11.
Review Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes. [Drugs Today (Barc). 2004]
Review Rosiglitazone maleate/metformin hydrochloride: a new formulation therapy for type 2 diabetes.
Cox SL. Drugs Today (Barc). 2004 Jul; 40(7):633-43.
Review Combination agents for diabetes. [Adv Nurse Pract. 2003]
Review Combination agents for diabetes.
Samuel J, Rochester CD. Adv Nurse Pract. 2003 Jun; 11(6):22-4.
Glyburide/metformin (Glucovance) for type 2 diabetes. [Med Lett Drugs Ther. 2000]
Glyburide/metformin (Glucovance) for type 2 diabetes.
[No authors listed]Med Lett Drugs Ther. 2000 Nov 13; 42(1092):105-6.
Metformin for cancer prevention. [Front Med. 2011]
Metformin for cancer prevention.
Yang Y. Front Med. 2011 Jun; 5(2):115-7.

Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells. [PLoS One. 2013]
Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
Soares HP, Ni Y, Kisfalvi K, Sinnett-Smith J, Rozengurt E. PLoS One. 2013; 8(2):e57289. Epub 2013 Feb 21.
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. [Am J Cancer Res. 2013]
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages.
Okwan-Duodu D, Umpierrez GE, Brawley OW, Diaz R. Am J Cancer Res. 2013; 3(1):21-33. Epub 2013 Jan 18.
Review Metformin in obesity, cancer and aging: addressing controversies. [Aging (Albany NY). 2012]
Review Metformin in obesity, cancer and aging: addressing controversies.
Berstein LM. Aging (Albany NY). 2012 May; 4(5):320-9.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Mysterious metformin.
Mysterious metformin.
Oncologist. 2009 Dec ;14(12):1178-81. doi: 10.1634/theoncologist.2009-0286. Epub 2009 Dec 10 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed